Belle Health is a women's health company focused on developing digital medical devices to empower women in managing menstrual cycle-related challenges, especially hormone-related conditions like premenstrual disorders (PMDD, PMS, dysmenorrhea). Founded in 2024 by Rafael and Victoria at the University of Cambridge, the company aims to bridge the female health gap using science and technology to provide personalized, evidence-based care. Their flagship offering, Belle's App, includes features like customizable PMDD tracking, cognitive behavioral therapy programs, and medically-endorsed reporting to support women affected by these conditions.

Belle Health's mission is to improve the overall health and well-being of women by addressing the lack of tailored healthcare solutions for female hormonal health issues. They focus on holistic, evidence-based approaches combining mind, body, and soul, aiming to empower women with knowledge, tools, and long-term support. The company is GDPR-compliant, prioritizes data privacy, and actively involves the community through public roadmaps and research collaborations.